Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Danuta Owczarek

The Importance of IL28B Polymorphism in Response to Pegylated Interferon Α and Ribavirin in Chronic Hepatitis Caused by HCV Genotype 1b

Przeglad Gastroenterologiczny

Gastroenterology

2012

English

Validation of the Metrological Model of Coordinate Measuring Arm Using Multifeature Check

Advances in Science and Technology Research Journal

2015

English

Related publications

miR-122, IL28B Genotype and the Response to Interferon in Chronic Hepatitis C Virus Infection

Nature Reviews Immunology

English

Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.

Acta Biochimica Polonica

English

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Journal of Medical Virology

Virology

Infectious Diseases

2012

English

Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients

Afro-Egyptian Journal of Infectious and Endemic Diseases

2016

English

A Case of Chronic Hepatitis C, Genotype 3b Relapsed After Interferon Monotherapy, Treated With Pegylated Interferon Plus Ribavirin and Achieved Sustained Virological Response

Acta Hepatologica Japonica

Hepatology

2015

English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

English

Treatment Response and Tolerability of Pegylated Interferon-Α Plus Ribavirin Combination Therapy in Elderly Patients (≥ 65 Years) With Chronic Hepatitis C in Korea

English

Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy

English

Safety and Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Combination in Treatment of Egyptian Patients With Chronic Hepatitis C Genotype-4

IOSR Journal of Pharmacy (IOSRPHR)

2014

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Danuta Owczarek

The Importance of IL28B Polymorphism in Response to Pegylated Interferon Α and Ribavirin in Chronic Hepatitis Caused by HCV Genotype 1b

Validation of the Metrological Model of Coordinate Measuring Arm Using Multifeature Check

Related publications

miR-122, IL28B Genotype and the Response to Interferon in Chronic Hepatitis C Virus Infection

Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients

A Case of Chronic Hepatitis C, Genotype 3b Relapsed After Interferon Monotherapy, Treated With Pegylated Interferon Plus Ribavirin and Achieved Sustained Virological Response

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

Treatment Response and Tolerability of Pegylated Interferon-Α Plus Ribavirin Combination Therapy in Elderly Patients (≥ 65 Years) With Chronic Hepatitis C in Korea

Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy

Safety and Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Combination in Treatment of Egyptian Patients With Chronic Hepatitis C Genotype-4